Institute for Myeloma & Bone Cancer Research

10/05/2025

Watch Dr. James Berenson's interview where he talks about a new treatment for multiple myeloma.

A video from James Berenson, posted on Sep 26, 2025.

09/22/2025

Your team at IMBCR wish you and yours a Happy and Healthy New Year.

08/23/2025

💪Mark, a grateful MM patient of Dr James Berenson celebrates three years taking a hike around Lake Tahoe. 👏 "It's important to Dr. B that patients experience their best quality of life." 

08/01/2025

Let's support an important cause: CANCER RESEARCH! For Dr. James R. Berenson's birthday, we are raising support for the groundbreaking work that the Institute for Myeloma & Bone Cancer Research (IMBCR) is conducting everyday. We have recently discovered a new target, i1, and compounds that block it which is leading to a brand-new approach to treating myeloma. Any gift will make an impact and is tax-deductible. We appreciate you and thank you for your donation. IMBCR.org/Donate

07/17/2025

📣 UPDATE on the new myeloma treatment we’ve all been working on: We’ve gotten a lot of questions asking if the new treatment we’re working on with the Institute for Myeloma & Bone Cancer Research will eventually be available outside of the US. Here’s Dr. B’s answer.

07/04/2025

We are continuing to get lots of questions about the new treatment we’re working on for getting rid of myeloma. The first question I’m going to answer is from David on Facebook. He asks “Is the new treatment you’re testing similar to ruxolitinib or something completely new?”

Institute for Myeloma & Bone Cancer Research

06/10/2025

We started Myeloma BioBank to help accelerate the discovery of new treatments and cures for myeloma and its related diseases; this BioBank provides support for ongoing research at the Institute for Myeloma & Bone Cancer Research (IMBCR).

We are able to provide researchers with the highest quality blood and bone marrow samples from multiple myeloma and other plasma cell dyscrasias, including MGUS, amyloidosis, and Waldenstrom’s macroglobulinemia.

05/31/2025

🎉 Last Chance to Bid on Amazing Auction Items! 🎉

Don’t miss your opportunity to win big while supporting IMBCR in the fight against cancer — our silent auction closes on Monday, June 2nd! ⏰ Check out the remaining items then email info@imbcr.org with your name, item number, and bid amount to place your final bids now! 🛍️

05/27/2025

Thank you to everybody that supported IMBCR’s Benefit Honoring Beverly and Eleda Cohen. The sold out event was so much fun. 🎉 Guests enjoyed live music, unbelievable silent auction items, and a delicious dinner. To top it off, Dr James Berenson gave an inspiring lecture “Myeloma 101” explaining what IMBCR does and the exciting groundbreaking research he and the scientists are discovering. 💪

05/27/2025

Thank you to everybody who supported IMBCR's successful sold out fundraiser. What a wonderful evening--live entertainment, a delicious dinner, and incredible silent auction items. And to top it off to learn about IMBCR and the exciting breakthrough discoveries the scientists are making in "Myeloma 101"--a lecture by Dr James Berenson.

05/11/2025

5 States of Myeloma: ⬇️

There are 5 different states of Myeloma disease. Have you heard of all of these?

🔹 1. MGUS: Stands for monoclonal gammopathy of undetermined significance. MGUS is when M-protein is found in the body, but there are not enough plasma cells to call it myeloma, and no treatment is required.

🔹2. Smoldering Myeloma: This is when there are enough plasma cells in the bone marrow (more than 10%) to call it myeloma, but there are no symptoms. Patients typically just require close monitoring.

🔹3. Plasmacytoma: is when a single group of abnormal plasma cells grow.

🔹4. Active myeloma: is where there are typically multiple symptoms, such as bone damage, fatigue, kidney failure, anemia, and a compromised immunity.

🔹5. Plasma Cell Leukemia: When the myeloma spreads from the bone marrow into the blood, it is known as plasma cell leukemia. Myeloma patients who develop this at diagnosis have a better outcome than those who develop it during the course of their disease.

No matter what stage, there are more treatments available now than ever before. 🎉
Give us a call at 310.623.1222 to schedule a consultation. 📞

05/06/2025

🎟️Hurry and get tickets to our annual benefit! 🎉Amazing silent auction items, three incredible raffle prizes, live music, delicious dinner well supporting groundbreaking cancer research. 💪 Call: 310-623-1214, Email:bboykin@IMBCR.org, IMBCR.org/Events